Drug companies expected to get more leeway in communicating with patients in Europe
AUTOR(ES)
Sayburn, Anna
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2137081Documentos Relacionados
- Responses from pharmaceutical companies to doctors’ requests for more drug information in Pakistan: postal survey
- Communicating with patients.
- Specialists should get more involved in the care of chronic patients
- Communicating about potential drug harms: safety implications for patients
- Software company defends sale of patients’ data to drug companies